Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor
US-2024402163-A1 · Dec 5, 2024 · US
US9310373B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9310373-B2 |
| Application number | US-201414181391-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 14, 2014 |
| Priority date | Nov 23, 2005 |
| Publication date | Apr 12, 2016 |
| Grant date | Apr 12, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method is disclosed for making a conjugate of two molecules using a hydrazide thiol linker. In a particular working embodiment, an Fc-specific antibody-enzyme conjugate is made using the method and demonstrated to provide exceptional staining sensitivity and specificity in immunohistochemical and in situ hybridization assays.
Opening claim text (preview).
We claim: 1. A kit, comprising: a conjugate, comprising an antibody, a detectable label comprising an enzyme including about 17-25 maleimide groups introduced into the enzyme by NHS-PEG-maleimide linkers, each linker being covalently bonded to an amino group of the enzyme, and a plurality of hydrazide thiol linkers, each hydrazide thiol linker comprising one or more linking atoms positioned between a hydrazide group and a thiol group, wherein the hydrazide thiol linker is selected from mercaptobutyric acid hydrazide (MBH), mercaptobutyric acid carbohydrazide (MBCH), mercaptoacetamido-mercaptobutyric acid hydrazide (MAMBH), thiohexanamidomercaptobutyric acid hydrazide (THMBH), N,N′-(6-hydrazinyl-6-oxohexane-1,5-diyl)bis(2-mercaptoacetamide) (BTAL), bisthiohexanamidohydrazidolysine (BTHL), N-(1,5-dihydrazinyl-1,5-dioxopentan-2-yl)2-mercaptoacetamide (TAGD), thiohexamidoglutamic acid dihydrazide (THGD), a PEG-based hydrazide-thiol linker, a multifunctional hydrazide thiol linker, a PEG-based multifunctional hydrazide thiol linker, a polyacrylamide hydrazide thiol linker, and combinations thereof, the hydrazide group of each hydrazide thiol linker being covalently bonded to an oxidized glycosylated Fc portion of the antibody and the thiol group of one of the hydrazide thiol linkers being covalently bonded to the detectable label via one of the maleimide groups. 2. The kit of claim 1 , wherein the hydrazide thiol linker comprises a PEG-based hydrazide thiol linker. 3. The kit of claim 2 , wherein the PEG-based hydrazide thiol linker comprises a mercapto-dPEG-hydrazide linker. 4. The kit of claim 1 , wherein the hydrazide thiol linker comprises MBH or MBCH. 5. The kit of claim 1 , wherein the enzyme is alkaline phosphatase or horseradish peroxidase. 6. The kit of claim 5 , wherein the enzyme is alkaline phosphatase. 7. The kit of claim 6 , wherein the alkaline phosphatase comprises cross-linked alkaline phosphatase. 8. The kit of claim 1 , wherein the antibody comprises an anti-hapten antibody. 9. The kit of claim 1 , wherein the antibody comprises an anti-antibody antibody. 10. A method for detecting a molecule of interest in a cell or tissue sample, comprising: contacting the cell or the tissue sample with a primary antibody specifically recognizing the molecule of interest in the cell or the tissue sample to provide the cell or the tissue sample bound with the primary antibody contacting the cell or tissue sample with a conjugate comprising an antibody capable of specifically recognizing the primary antibody, a detectable label comprising an enzyme including about 17-25 maleimide groups introduced into the enzyme by NHS-PEG-maleimide linkers, each linker being covalently bonded to an amino group of the enzyme, and a plurality of hydrazide thiol linkers, each hydrazide thiol linker comprising one or more linking atoms positioned between a hydrazide group and a thiol group, wherein the hydrazide thiol linker is selected from mercaptobutyric acid hydrazide (MBH), mercaptobutyric acid carbohydrazide (MBCH), mercaptoacetamido-mercaptobutyric acid hydrazide (MAMBH), thiohexanamidomercaptobutyric acid hydrazide (THMBH), N,N′-(6-hydrazinyl-6-oxohexane-1,5-diyl)bis(2-mercaptoacetamide) (BTAL), bisthiohexanamidohydrazidolysine (BTHL), N-(1,5-dihydrazinyl-1,5-dioxopentan-2-yl)2-mercaptoacetamide (TAGD), thiohexamidoglutamic acid dihydrazide (THGD), a PEG-based hydrazide-thiol linker, a multifunctional hydrazide thiol linker, a PEG-based multifunctional hydrazide thiol linker, a polyacrylamide hydrazide thiol linker, and combinations thereof, the hydrazide group of each hydrazide thiol linker being covalently bonded to an oxidized glycosylated Fc portion of the antibody and the thiol group of one of the hydrazide thiol linkers being covalently bonded to one of the maleimide groups on the enzyme; and detecting a signal generated by the conjugate that are bound to the primary antibody indicating the presence of the molecule of interest in the cell or tissue sample. 11. The method of claim 10 , wherein the hydrazide thiol linker comprises a PEG-based hydrazide thiol linker. 12. The method of claim 11 , wherein the PEG-based hydrazide thiol linker comprises a mercapto-dPEG-hydrazide linker. 13. The method of claim 10 , wherein the hydrazide thiol linker comprises MBH or MBCH. 14. The method of claim 10 , wherein the enzyme is alkaline phosphatase or horseradish peroxidase. 15. The method of claim 14 , wherein the enzyme is alkaline phosphatase. 16. The method of claim 15 , wherein the alkaline phosphatase comprises cross-linked alkaline phosphatase.
having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms · CPC title
with enzyme label {or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates} · CPC title
Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies · CPC title
Production of labelled immunochemicals · CPC title
Antibodies bound to carriers · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.